Business · 20/12/2005
FDA Amends Animal Drug Regulations Due to Change in Sponsor for New Chloramphenicol Capsules
The FDA is updating its regulations to reflect a change in sponsor for a new animal drug application for chloramphenicol capsules, shifting from Nylos Trading Co., Inc. to Pharmaceutical Ventures, Ltd.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →